Ovarian Cancer Vaccine for Patients in Remission

Clinical trial NCT01068509 · COMPLETED

Trial details

NCT number: NCT01068509
Sponsor: Prima BioMed Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2010-07-01
Primary completion: 2013-08-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.